Work

Supplementary Fig. S2 from ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Fig. S2 from ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo

DOI: 10.1158/1535-7163.22482998.v1

Authors: Scott Ackler, Yu Xiao, Michael J. Mitten, Kelly Foster, Anatol Oleksijew, Marion Refici, Sally Schlessinger, Baole Wang, Sanjay R. Chemburkar, Joy Bauch, Christin Tse, David J. Frost, Stephen W. Fesik, Saul H. Rosenberg, Steven W. Elmore, Alex R. Shoemaker

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361813751

Cites:

Cited by:

Related to: 10